Figure 9.
Comparison of clinical symptoms of dextran sulfate sodium (DSS)-induced inflammatory bowel disease (IBD) treated with 20 mg/kg Tan IIA or 45 mg/kg PCN in WT and PXR siRNA-treated mouse model.
Notes: (A) Histology scores and (B) changes in body weight after DSS induction of colitis; (C) Diarrhea scores; (D) Bleeding scores; Marked statistical distinction can be found between PXR-silenced mice and WT mice; Mice with silenced PXR expression cotreated with 20 mg/kg Tan IIA or 45 mg/kg PCN could slightly aggravate severity in DSS-induced IBD, and the therapeutic effect was significantly reduced in PXR-silenced mice compared with WT mice; Each bar represents the means ± SD (n=10); ##P<0.05, ###P<0.001 versus vehicle-treated group; *P<0.01 represents WT versus PXR siRNA-treated mouse model group.
Abbreviations: PCN, pregnenolone 16a-carbonitrile; PXR, pregnane X receptor; SD, standard deviation; siRNA, small interfering RNA; Tan IIA, tanshinone IIA; WT, wild-type.